Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • AaronS
    Junior Member
    • Dec 2010
    • 4

    #1

    MIRA Question: Improving 454 assembly with RNAseq data

    Hi All,

    I’d like to do a hybrid assembly of 454 genomic sequence and illumina RNAseq data using MIRA. Unfortunately, I’m not really sure how to do an assembly with 2 different technologies AND 2 different types of data (genomic DNA from 454 and RNA from Illumina). I’m concerned that highly expressed genes will be flagged as repetitive sequence because reads from those genes will be over-represented in the sample.

    I have a draft assembly of a bacterial genome generated with 454 reads using newbler. However, when I mapped my RNAseq data to this assembly, only a very low percentage of reads mapped back to the genome. I did this previously for a different bacterial isolate, and everything worked well (>97% of reads mapped to genome generated from assembly of 454 data). However, for this latest strain, I think there is a problem with either the coverage or the assembly, so I’d like to use as much data as possible to get a better assembly.

    Does anyone have any advice on the best way to incorporate both data types into a denovo genome assembly using MIRA?

    Thanks for all your help.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...